Commonwealth Equity Services’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Sell
214,860
-1,544
-0.7% -$12.2K ﹤0.01% 2277
2026
Q1
$1.47M Buy
216,404
+102,892
+91% +$761K ﹤0.01% 2272
2025
Q4
$1.32M Sell
113,512
-5,261
-4% -$58.2K ﹤0.01% 2353
2025
Q3
$1.38M Buy
118,773
+6,202
+6% +$75K ﹤0.01% 2327
2025
Q2
$1.39M Sell
112,571
-1,115
-1% -$12.3K ﹤0.01% 2300
2025
Q1
$700K Buy
113,686
+2,904
+3% +$30.1K ﹤0.01% 2759
2024
Q4
$897K Buy
110,782
+16,030
+17% +$160K ﹤0.01% 2472
2024
Q3
$766K Hold
94,752
﹤0.01% 2547
2024
Q2
$410K Buy
94,752
+56,963
+151% +$289K ﹤0.01% 3014
2024
Q1
$160K Hold
37,789
﹤0.01% 3695
2023
Q4
$142K Buy
37,789
+22,800
+152% +$78.5K ﹤0.01% 3605
2023
Q3
$55K Sell
14,989
-1,000
-6% -$3.98K ﹤0.01% 3646
2023
Q2
$63K Sell
15,989
-10,000
-38% -$49.5K ﹤0.01% 3633
2023
Q1
$107 Hold
25,989
﹤0.01% 3481
2022
Q4
$109K Buy
25,989
+400
+2% +$1.42K ﹤0.01% 3402
2022
Q3
$72K Hold
25,589
﹤0.01% 3432
2022
Q2
$102K Buy
+25,589
New +$95.1K ﹤0.01% 3365
2018
Q3
Sell
-5,017
Closed -$6K 2805
2018
Q2
$6K Buy
5,017
+1,740
+53% +$2.01K ﹤0.01% 2757
2018
Q1
$2K Hold
3,277
﹤0.01% 2709
2017
Q4
$8K Hold
3,277
﹤0.01% 2673
2017
Q3
$9K Hold
3,277
﹤0.01% 2561
2017
Q2
$7K Buy
+3,277
New +$11.2K ﹤0.01% 2515
2016
Q3
Sell
-2,018
Closed -$20K 2263
2016
Q2
$20K Hold
2,018
﹤0.01% 2200
2016
Q1
$27K Hold
2,018
﹤0.01% 2160
2015
Q4
$20K Buy
+2,018
New +$23.2K ﹤0.01% 2149

Other funds holding CRMD

Commonwealth Equity Services's CRMD Position: Q2 2026 in Review

Commonwealth Equity Services reduced its CorMedix (CRMD) stake by 0.71% in Q2 2026, selling an estimated $12.2K and leaving 214,860 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Commonwealth Equity Services first reported a position in CRMD in Q4 2015 and has held it in 25 quarters since. 34 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Commonwealth Equity Services held 214,860 shares of CorMedix worth $1.69M as of Q2 2026.
  • Commonwealth Equity Services sold 1,544 CorMedix shares in Q2 2026, an estimated $12.2K.
  • CorMedix made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2277 holding.
  • Commonwealth Equity Services first reported a position in CorMedix in Q4 2015 and has held it in 25 quarters since.
  • 34 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.